| Mark Smolik, MD | |
|
411 Laurel St, Suite 2100, Des Moines, IA 50314-3017 | |
| (515) 247-3266 | |
| (515) 643-8688 |
| Full Name | Mark Smolik |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 33 Years |
| Location | 411 Laurel St, Des Moines, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124133087 | NPI | - | NPPES |
| 6120089 | Medicaid | IA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 28916 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercyone Des Moines Medical Center | Des moines, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mercy Clinics Inc | 7911810882 | 373 |
News Archive
Researchers at the University of Liverpool's Institute of Infection and Global Health have discovered the pattern of infection of the bacterium responsible for causing severe lung infections in people with cystic fibrosis.
Seattle Genetics, Inc. today announced that its collaborator, Takeda Pharmaceutical Company Limited, has received approval of ADCETRIS (brentuximab vedotin) from the Japanese Ministry of Health, Labour and Welfare for the treatment of patients with CD30-positive relapsed or refractory Hodgkin lymphoma and anaplastic large cell lymphoma.
Imagenetix, Inc. announced today results for the three and nine months ended December 31, 2010. Net sales decreased 4% for the third quarter of fiscal year 2011 to $1,696,000 from $1,765,000 for the same period of last year. A loss of $1,202,000, $0.10 per share, was reported for the third quarter of fiscal year 2011, compared to a net loss of $294,000, $.03 per share, for the same period of the prior fiscal year.
Australia's New South Wales (NSW) government announced radical laws that ban commercial tanning beds in the state. NSW will be the only place in the world besides Brazil to institute a total ban on ultraviolet solariums tanning units when the laws come into place from December 31, 2014, and cancer groups hope other states and countries will follow.
According to a Food and Drug Administration official, regulators may take months to review public comments on Barr Pharmaceuticals Inc.'s application to sell the Plan B "morning-after" contraceptive without a prescription.
› Verified 6 days ago
| Entity Name | Mercy Clinics Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457691941 PECOS PAC ID: 7911810882 Enrollment ID: O20031112000238 |
News Archive
Researchers at the University of Liverpool's Institute of Infection and Global Health have discovered the pattern of infection of the bacterium responsible for causing severe lung infections in people with cystic fibrosis.
Seattle Genetics, Inc. today announced that its collaborator, Takeda Pharmaceutical Company Limited, has received approval of ADCETRIS (brentuximab vedotin) from the Japanese Ministry of Health, Labour and Welfare for the treatment of patients with CD30-positive relapsed or refractory Hodgkin lymphoma and anaplastic large cell lymphoma.
Imagenetix, Inc. announced today results for the three and nine months ended December 31, 2010. Net sales decreased 4% for the third quarter of fiscal year 2011 to $1,696,000 from $1,765,000 for the same period of last year. A loss of $1,202,000, $0.10 per share, was reported for the third quarter of fiscal year 2011, compared to a net loss of $294,000, $.03 per share, for the same period of the prior fiscal year.
Australia's New South Wales (NSW) government announced radical laws that ban commercial tanning beds in the state. NSW will be the only place in the world besides Brazil to institute a total ban on ultraviolet solariums tanning units when the laws come into place from December 31, 2014, and cancer groups hope other states and countries will follow.
According to a Food and Drug Administration official, regulators may take months to review public comments on Barr Pharmaceuticals Inc.'s application to sell the Plan B "morning-after" contraceptive without a prescription.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mark Smolik, MD Po Box 1475, Des Moines, IA 50305-1475 Ph: (515) 247-3266 | Mark Smolik, MD 411 Laurel St, Suite 2100, Des Moines, IA 50314-3017 Ph: (515) 247-3266 |
News Archive
Researchers at the University of Liverpool's Institute of Infection and Global Health have discovered the pattern of infection of the bacterium responsible for causing severe lung infections in people with cystic fibrosis.
Seattle Genetics, Inc. today announced that its collaborator, Takeda Pharmaceutical Company Limited, has received approval of ADCETRIS (brentuximab vedotin) from the Japanese Ministry of Health, Labour and Welfare for the treatment of patients with CD30-positive relapsed or refractory Hodgkin lymphoma and anaplastic large cell lymphoma.
Imagenetix, Inc. announced today results for the three and nine months ended December 31, 2010. Net sales decreased 4% for the third quarter of fiscal year 2011 to $1,696,000 from $1,765,000 for the same period of last year. A loss of $1,202,000, $0.10 per share, was reported for the third quarter of fiscal year 2011, compared to a net loss of $294,000, $.03 per share, for the same period of the prior fiscal year.
Australia's New South Wales (NSW) government announced radical laws that ban commercial tanning beds in the state. NSW will be the only place in the world besides Brazil to institute a total ban on ultraviolet solariums tanning units when the laws come into place from December 31, 2014, and cancer groups hope other states and countries will follow.
According to a Food and Drug Administration official, regulators may take months to review public comments on Barr Pharmaceuticals Inc.'s application to sell the Plan B "morning-after" contraceptive without a prescription.
› Verified 6 days ago
Jan Franko, MD, PHD Surgery Medicare: Accepting Medicare Assignments Practice Location: 411 Laurel St, Ste 2100, Des Moines, IA 50314 Phone: 515-247-3266 Fax: 515-643-8688 | |
Ashlea Semmens, MD Surgery Medicare: Medicare Enrolled Practice Location: 1415 Woodland Ave, Ste 140, Des Moines, IA 50309 Phone: 515-241-4076 | |
Dr. Ze-hui Han, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 450 Laurel St, Ste. A, Des Moines, IA 50314 Phone: 515-247-8400 Fax: 515-248-8888 | |
Dr. Yuichi Ishida, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 411 Laurel St Ste A250, Des Moines, IA 50314 Phone: 515-235-5000 Fax: 515-288-6713 | |
Dr. Richard Sidwell, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1212 Pleasant St, Suite 211, Des Moines, IA 50309 Phone: 515-875-9770 Fax: 515-875-9771 | |
Dr. Robert Louis Clark Jr., MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 3600 30th St, Des Moines, IA 50310 Phone: 515-699-5826 Fax: 515-699-5929 | |
Alexander M Stock, MD Surgery Medicare: Medicare Enrolled Practice Location: 1200 Pleasant St, Des Moines, IA 50309 Phone: 515-241-4078 |